Rainbow Children's Medicare Q4 FY26 Revenue Up 24.3% to ₹4,599 Crore, PAT Rises 38.3%
Rainbow Children’s Medicare reported Q4 FY26 revenue of ₹4,599 million, up 24.3% YoY. PAT grew 38.3% to ₹782 million. FY26 revenue increased 12.4% to ₹17,031 million, with PAT up 15.3% to ₹2,815 million. The company recommended a final dividend of 35% and is shifting focus to execution and operational optimization.
The announcement details significant financial performance improvements (revenue and profit growth), strategic expansion completions, and a dividend payout, all of which are material events for investors and stakeholders.
The company reported strong year-on-year growth in both revenue and profit for the quarter and the full financial year. The announcement also includes positive operational updates and a recommended dividend, indicating a positive financial and strategic outlook.
Rainbow Children’s Medicare Limited (RCML) announced strong financial results for the fourth quarter and financial year ended March 31, 2026. The company reported a 24.3% year-on-year increase in revenue for Q4 FY26, reaching ₹4,599 million (₹459.9 crore), compared to ₹3,701 million (₹370.1 crore) in Q4 FY25. Profit After Tax (PAT) saw a significant jump of 38.3%, from ₹566 million (₹56.6 crore) to ₹782 million (₹78.2 crore) in the same period. For the full financial year FY26, revenue grew by 12.4% to ₹17,031 million (₹1,703.1 crore), and PAT increased by 15.3% to ₹2,815 million (₹281.5 crore). The company also noted strong operational performance with a 19% increase in operational beds and a 22% rise in deliveries year-on-year. RCML has completed its current phase of capacity expansion, which includes new facilities in Bengaluru and upcoming projects in Coimbatore, Gurugram, and Pune. The company's Board has recommended a final dividend of 35% per equity share, amounting to ₹355.5 million (₹35.55 crore).
Dr. Ramesh Kancharla, Chairman & Managing Director, highlighted the healthy momentum across the network and the successful scaling up of newer hospitals. He emphasized that the focus will now shift towards execution, clinical excellence, improving occupancies, and building sustainable growth. Mr. Abrar Ali Dalal has transitioned into the CEO role, overseeing operations and execution. The company maintains a robust balance sheet with cash and equivalents totaling ₹5,942 million (₹594.2 crore) as of March 31, 2026, sufficient to fund ongoing capital expenditures and potential M&A activities.
What to do with a filing like this
Rainbow Childrens Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rainbow Childrens Medicare Limited. Read the original for the full detail.